Determination of the intracellular signaling pathways that control intestinal epithelial proliferation is fundamental to the understanding of the integrity and function of the intestinal tract under normal and diseased conditions. The phosphatidylinositol 3-kinase (PI3K)/Akt pathway transduces signals initiated by growth factors and is involved in cell proliferation, cell differentiation, and programmed cell death. Our in vivo and in vitro studies demonstrate that PI3K transduces mitogenic signals initiated by growth factors, regulates expression of important cell cycle-related proteins, and controls intestinal epithelial proliferation.
Specific Aim 1 of this application is to determine the critical role of PI3K in intestinal epithelial proliferation using animal models in which gut mucosal proliferation will be induced by growth factors and small bowel resection. Intestinal localization of PI3K activity, cyclin D1 protein, and epithelial proliferation will be evaluated. The second Specific Aim will delineate the molecular mechanisms by which PI3K and its downstream effectors regulate intestinal epithelial cell proliferation. The regulation and functional role of cyclin D1 and p27/Kip in PI3K-mediated intestinal epithelial proliferation will be elucidated.
In Specific Aim 3, we will determine whether functional gain in PI3K improves intestinal mucosal proliferation employing knockout mice and transgenic mice in which PI3K activity is functionally upregulated. Regulation of intestine-specific genes by PI3K activation will be investigated in these animal models. The long-term goal of this proposal is to provide a complete assessment of intracellular signaling mechanisms that control intestinal epithelial proliferation and to provide clinically relevant information regarding stimulation of intestinal growth during periods of gut disuse, after small bowel resection, or with administration of chemotherapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK064593-01A1
Application #
6772111
Study Section
Special Emphasis Panel (ZRG1-SSS-8 (02))
Program Officer
Hamilton, Frank A
Project Start
2004-04-01
Project End
2004-06-30
Budget Start
2004-04-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$42,504
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Surgery
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Shao, Jinyi; Washington, M Kay; Saxena, Romil et al. (2007) Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin. Carcinogenesis 28:2476-83
Shao, Jinyi; Sheng, Hongmiao (2007) Prostaglandin E2 induces the expression of IL-1alpha in colon cancer cells. J Immunol 178:4097-103
Shao, Jinyi; Sheng, George G; Mifflin, Randy C et al. (2006) Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res 66:846-55
Shao, Jinyi; Jung, Chaeyong; Liu, Chunming et al. (2005) Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 280:26565-72